Pablo Umaña

Person

Wollerau, CH

People

Patents Grantslast 30 patents

Information Patent Grant
Anti-FAP antibodies and methods of use
- Patent number 12,286,486
- Issue date Apr 29, 2025
- Roche GlycArt AG
- Marina Bacac
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Combination therapy with targeted 4-1BB (CD137) agonists
- Patent number 12,281,153
- Issue date Apr 22, 2025
- HOFFMANN-LA ROCHE INC.
- Christina Claus
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific antigen binding molecules comprising anti-FAP clone 212
- Patent number 12,275,794
- Issue date Apr 15, 2025
- HOFFMANN-LA ROCHE INC.
- Peter Bruenker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Stabilized immunoglobulin domains
- Patent number 12,258,371
- Issue date Mar 25, 2025
- Hoffman-La Roche Inc.
- Laura Deak Codarri
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific antibodies specific for OX40
- Patent number 12,240,911
- Issue date Mar 4, 2025
- HOFFMANN-LA ROCHE INC.
- Maria Amann
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antibodies binding to CD3 and CD19
- Patent number 12,215,155
- Issue date Feb 4, 2025
- HOFFMANN-LA ROCHE INC.
- Anne Freimoser-Grundschober
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antigen binding molecules comprising a trimeric TNF family ligand a...
- Patent number 12,202,870
- Issue date Jan 21, 2025
- HOFFMANN-LA ROCHE INC.
- Maria Amann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific antigen binding molecules capable of specific binding to...
- Patent number 12,145,994
- Issue date Nov 19, 2024
- HOFFMANN-LA ROCHE INC.
- Peter Bruenker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
T cell activating bispecific antigen binding molecules
- Patent number 12,139,553
- Issue date Nov 12, 2024
- HOFFMANN-LA ROCHE INC.
- Marina Bacac
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
T cell activating bispecific antigen binding molecules
- Patent number 12,103,982
- Issue date Oct 1, 2024
- HOFFMANN-LA ROCHE INC.
- Christian Klein
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antibodies binding to HLA-A2/WT1
- Patent number 12,098,213
- Issue date Sep 24, 2024
- HOFFMANN-LA ROCHE INC.
- Joerg Benz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
HER2-targeting antigen binding molecules comprising 4-1BBL
- Patent number 12,065,478
- Issue date Aug 20, 2024
- HOFFMANN-LA ROCHE INC.
- Claudia Ferrara Koller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Agonistic CD28 antigen binding molecules targeting Her2
- Patent number 12,049,515
- Issue date Jul 30, 2024
- HOFFMANN-LA ROCHE INC.
- Stephan Gasser
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunoconjugates
- Patent number 12,023,368
- Issue date Jul 2, 2024
- HOFFMANN-LA ROCHE INC.
- Laura Codarri Deak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies binding to HLA-A2/MAGE-A4
- Patent number 11,987,632
- Issue date May 21, 2024
- HOFFMANN-LA ROCHE INC.
- Tina Weinzierl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific antibodies against CD3EPSILON and ROR1
- Patent number 11,952,421
- Issue date Apr 9, 2024
- Bristol-Myers Squibb Company
- Minh Diem Vu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapy of PD-1-targeted IL-2 variant immunocytokines a...
- Patent number 11,865,082
- Issue date Jan 9, 2024
- HOFFMANN-LA ROCHE INC.
- Laura Codarri Deak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies binding to NKG2D
- Patent number 11,827,711
- Issue date Nov 28, 2023
- HOFFMANN-LA ROCHE INC.
- Stefan Dengl
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific HER2 antibodies and methods of use
- Patent number 11,787,873
- Issue date Oct 17, 2023
- HOFFMANN-LA ROCHE INC.
- Rebecca Croasdale-Wood
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antibodies binding to CD3 and CD19
- Patent number 11,780,920
- Issue date Oct 10, 2023
- HOFFMANN-LA ROCHE INC.
- Anne Freimoser-Grundschober
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific antigen binding molecules targeting OX40 and FAP
- Patent number 11,780,919
- Issue date Oct 10, 2023
- HOFFMANN-LA ROCHE INC.
- Maria Amann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapy of anti-CD20/anti-CD3 bispecific antibodies and...
- Patent number 11,718,680
- Issue date Aug 8, 2023
- HOFFMANN-LA ROCHE INC.
- Marina Bacac
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific antibody molecules binding to CD3 and TYRP-1
- Patent number 11,672,858
- Issue date Jun 13, 2023
- HOFFMANN-LA ROCHE INC.
- Anne Freimoser-Grundschober
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific antibodies specific for T-cell activating antigens and a...
- Patent number 11,639,397
- Issue date May 2, 2023
- Roche Glycart AG
- Peter Bruenker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific antigen binding molecule for a costimulatory TNF receptor
- Patent number 11,639,394
- Issue date May 2, 2023
- HOFFMANN-LA ROCHE INC.
- Sandra Grau-Richards
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapy of T cell activating bispecific antigen binding...
- Patent number 11,613,587
- Issue date Mar 28, 2023
- HOFFMANN-LA ROCHE INC.
- Christian Klein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tumor-targeted agonistic CD28 antigen binding molecules
- Patent number 11,608,376
- Issue date Mar 21, 2023
- HOFFMANN-LA ROCHE INC.
- Guy Georges
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific antibody molecules binding to CD3 and EGFRvIII
- Patent number 11,591,397
- Issue date Feb 28, 2023
- HOFFMANN-LA ROCHE INC.
- Anne Freimoser-Grundschober
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific T cell activating antigen binding molecules
- Patent number 11,459,404
- Issue date Oct 4, 2022
- Roche Glycart AG
- Marina Bacac
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific antigen binding molecule for a costimulatory TNF receptor
- Patent number 11,453,722
- Issue date Sep 27, 2022
- HOFFMANN-LA ROCHE INC.
- Maria Amann
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
ANTIBODIES BINDING TO HLA-A2/WT1
- Publication number 20250129179
- Publication date Apr 24, 2025
- HOFFMANN-LA ROCHE INC.
- Joerg Benz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF ANTI-TYRP1/ANTI-CD3 BISPECIFIC ANTIBODIES AN...
- Publication number 20250101132
- Publication date Mar 27, 2025
- HOFFMANN-LA ROCHE INC.
- Christian Klein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIGEN BINDING MOLECULES COMPRISING A TNF FAMILY LIGAND TRIMER
- Publication number 20250101135
- Publication date Mar 27, 2025
- HOFFMANN-LA ROCHE INC.
- Maria Amann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FOLR1 PROTEASE-ACTIVATABLE T CELL BISPECIFIC ANTIBODIES
- Publication number 20250092128
- Publication date Mar 20, 2025
- HOFFMANN-LA ROCHE INC.
- Peter BRUENKER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Immunoconjugates
- Publication number 20250073308
- Publication date Mar 6, 2025
- HOFFMANN-LA ROCHE INC.
- Laura Codarri Deak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HER2-TARGETING ANTIGEN BINDING MOLECULES COMPRISING 4-1BBL
- Publication number 20250066448
- Publication date Feb 27, 2025
- HOFFMANN-LA ROCHE INC.
- Claudia FERRARA KOLLER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AGONISTIC CD28 ANTIGEN BINDING MOLECULES TARGETING HER2
- Publication number 20250059298
- Publication date Feb 20, 2025
- HOFFMANN-LA ROCHE INC.
- Stephan GASSER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES
- Publication number 20250043028
- Publication date Feb 6, 2025
- Roche Glycart AG
- Oliver AST
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AGONISTIC LTBR ANTIBODIES AND BISPECIFIC ANTIBODIES COMPRISING THEM
- Publication number 20250034269
- Publication date Jan 30, 2025
- HOFFMANN-LA ROCHE INC.
- Roberta Bianchi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES
- Publication number 20240425616
- Publication date Dec 26, 2024
- Roche Glycart AG
- Oliver AST
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NEW INTERLEUKIN-7 IMMUNOCONJUGATES
- Publication number 20240425561
- Publication date Dec 26, 2024
- HOFFMANN-LA ROCHE INC.
- Alejandro CARPY GUTIERREZ CIRLOS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES BINDING TO HLA-A2/MAGE-A4
- Publication number 20240383987
- Publication date Nov 21, 2024
- HOFFMANN-LA ROCHE INC.
- Tina Weinzierl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEASE-ACTIVATED POLYPEPTIDES
- Publication number 20240376171
- Publication date Nov 14, 2024
- HOFFMANN-LA ROCHE INC.
- Samuele CALABRO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETED INTERFERON ALPHA FUSION PROTEINS AND METHODS OF USE
- Publication number 20240376205
- Publication date Nov 14, 2024
- HOFFMANN-LA ROCHE INC.
- Jack Anthony BATES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AGONISTIC CD28 ANTIGEN BINDING MOLECULES TARGETING EPCAM
- Publication number 20240368309
- Publication date Nov 7, 2024
- HOFFMANN-LA ROCHE INC.
- Stephan GASSER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIGEN BINDING MOLECULES WITH INCREASED FC RECEPTOR BINDING AFFINI...
- Publication number 20240301079
- Publication date Sep 12, 2024
- Roche Glycart AG
- Pablo UMAÑA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ALTERNATIVE PD1-IL7V IMMUNOCONJUGATES FOR THE TREATMENT OF CANCER
- Publication number 20240269277
- Publication date Aug 15, 2024
- HOFFMANN-LA ROCHE INC.
- Laura CODARRI DEAK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF PD-1-TARGETED IL-2 VARIANT IMMUNOCONJUGATE A...
- Publication number 20240262913
- Publication date Aug 8, 2024
- HOFFMANN-LA ROCHE INC.
- Laura CODARRI DEAK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF PD-1-TARGETED IL-2 VARIANT IMMUNOCYTOKINES A...
- Publication number 20240216471
- Publication date Jul 4, 2024
- HOFFMANN-LA ROCHE INC.
- Laura CODARRI DEAK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES
- Publication number 20240141044
- Publication date May 2, 2024
- HOFFMANN-LA ROCHE INC.
- Oliver AST
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES BINDING TO CD3 and CD19
- Publication number 20240132590
- Publication date Apr 25, 2024
- HOFFMANN-LA ROCHE INC.
- Anne Freimoser-Grundschober
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIGEN BINDING MOLECULES TARGETING OX40 AND FAP
- Publication number 20240117049
- Publication date Apr 11, 2024
- HOFFMANN-LA ROCHE INC.
- Maria AMANN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMBINATION THERAPY OF ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES AND...
- Publication number 20240109976
- Publication date Apr 4, 2024
- HOFFMANN-LA ROCHE INC.
- Marina Bacac
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF PD-1 AXIS BINDING ANTAGONISTS AND LRRK2 INHI...
- Publication number 20240100063
- Publication date Mar 28, 2024
- HOFFMANN-LA ROCHE INC.
- Denise Corti
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF PD-1-TARGETED IL-2 VARIANT IMMUNOCONJUGATES...
- Publication number 20240092856
- Publication date Mar 21, 2024
- HOFFMANN-LA ROCHE INC.
- Marina BACAC
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PH-DEPENDENT MUTANT INTERLEUKIN-2 POLYPEPTIDES
- Publication number 20240092853
- Publication date Mar 21, 2024
- HOFFMANN-LA ROCHE INC.
- Lorenzo DEHO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies binding to NKG2D
- Publication number 20240067734
- Publication date Feb 29, 2024
- HOFFMANN-LA ROCHE INC.
- Stefan DENGL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES BINDING TO CD3
- Publication number 20240042022
- Publication date Feb 8, 2024
- HOFFMANN-LA ROCHE INC.
- Anne FREIMOSER-GRUNDSCHOBER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMMUNE ACTIVATING Fc DOMAIN BINDING MOLECULES
- Publication number 20240043535
- Publication date Feb 8, 2024
- HOFFMANN-LA ROCHE INC.
- Maria Amann
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PREVENTION OR MITIGATION OF T-CELL ENGAGING AGENT-RELATED ADVERSE E...
- Publication number 20230416412
- Publication date Dec 28, 2023
- HOFFMANN-LA ROCHE INC.
- Gabrielle LECLERCQ-COHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Pablo Umaña

Person

Patents Grantslast 30 patents

Anti-FAP antibodies and methods of use

Combination therapy with targeted 4-1BB (CD137) agonists

Bispecific antigen binding molecules comprising anti-FAP clone 212

Stabilized immunoglobulin domains

Bispecific antibodies specific for OX40

Antibodies binding to CD3 and CD19

Antigen binding molecules comprising a trimeric TNF family ligand a...

Bispecific antigen binding molecules capable of specific binding to...

T cell activating bispecific antigen binding molecules

T cell activating bispecific antigen binding molecules

Antibodies binding to HLA-A2/WT1

HER2-targeting antigen binding molecules comprising 4-1BBL

Agonistic CD28 antigen binding molecules targeting Her2

Immunoconjugates

Antibodies binding to HLA-A2/MAGE-A4

Bispecific antibodies against CD3EPSILON and ROR1

Combination therapy of PD-1-targeted IL-2 variant immunocytokines a...

Antibodies binding to NKG2D

Bispecific HER2 antibodies and methods of use

Antibodies binding to CD3 and CD19

Bispecific antigen binding molecules targeting OX40 and FAP

Combination therapy of anti-CD20/anti-CD3 bispecific antibodies and...

Bispecific antibody molecules binding to CD3 and TYRP-1

Bispecific antibodies specific for T-cell activating antigens and a...

Bispecific antigen binding molecule for a costimulatory TNF receptor

Combination therapy of T cell activating bispecific antigen binding...

Tumor-targeted agonistic CD28 antigen binding molecules

Bispecific antibody molecules binding to CD3 and EGFRvIII

Bispecific T cell activating antigen binding molecules

Bispecific antigen binding molecule for a costimulatory TNF receptor

Patents Applicationslast 30 patents

ANTIBODIES BINDING TO HLA-A2/WT1

COMBINATION THERAPY OF ANTI-TYRP1/ANTI-CD3 BISPECIFIC ANTIBODIES AN...

ANTIGEN BINDING MOLECULES COMPRISING A TNF FAMILY LIGAND TRIMER

FOLR1 PROTEASE-ACTIVATABLE T CELL BISPECIFIC ANTIBODIES

Immunoconjugates

HER2-TARGETING ANTIGEN BINDING MOLECULES COMPRISING 4-1BBL

AGONISTIC CD28 ANTIGEN BINDING MOLECULES TARGETING HER2

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

AGONISTIC LTBR ANTIBODIES AND BISPECIFIC ANTIBODIES COMPRISING THEM

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

NEW INTERLEUKIN-7 IMMUNOCONJUGATES

ANTIBODIES BINDING TO HLA-A2/MAGE-A4

PROTEASE-ACTIVATED POLYPEPTIDES

TARGETED INTERFERON ALPHA FUSION PROTEINS AND METHODS OF USE

AGONISTIC CD28 ANTIGEN BINDING MOLECULES TARGETING EPCAM

ANTIGEN BINDING MOLECULES WITH INCREASED FC RECEPTOR BINDING AFFINI...

ALTERNATIVE PD1-IL7V IMMUNOCONJUGATES FOR THE TREATMENT OF CANCER

COMBINATION THERAPY OF PD-1-TARGETED IL-2 VARIANT IMMUNOCONJUGATE A...

COMBINATION THERAPY OF PD-1-TARGETED IL-2 VARIANT IMMUNOCYTOKINES A...

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

ANTIBODIES BINDING TO CD3 and CD19

BISPECIFIC ANTIGEN BINDING MOLECULES TARGETING OX40 AND FAP

COMBINATION THERAPY OF ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES AND...

COMBINATION THERAPY OF PD-1 AXIS BINDING ANTAGONISTS AND LRRK2 INHI...

COMBINATION THERAPY OF PD-1-TARGETED IL-2 VARIANT IMMUNOCONJUGATES...

PH-DEPENDENT MUTANT INTERLEUKIN-2 POLYPEPTIDES

Antibodies binding to NKG2D

ANTIBODIES BINDING TO CD3

IMMUNE ACTIVATING Fc DOMAIN BINDING MOLECULES

PREVENTION OR MITIGATION OF T-CELL ENGAGING AGENT-RELATED ADVERSE E...